Notably, researchers observed no similar reduction in hospitalizations unrelated to alcohol in T2D populations and smaller impacts on hospitalizations unrelated to alcohol in populations with obesity, suggesting the effect may be specific to alcohol-related outcomes, rather than confounding by underlying health status or general improvements in health
predicts diabetes risk and monitors long-term glycemic control Lipid panel: Total cholesterol, LDL, HDL, triglycerides Liver and kidney function: AST, ALT, creatinine, eGFR
A program, not a subscription A 12-week medical protocol with a beginning, middle, and end
Fiber: Fibers from oats, legume, flaxseeds, and fruits and vegetables slow digestion and stabilize blood sugar, leading to a higher GLP-1 release
Because patients may receive GLP-1 prescriptions from primary care, endocrinology, or obesity medicine specialists, coordination with obstetrics and gynecology is essential
The median dose of insulin glargine at end of study was 0.45 U/kg
